GBLX - GB Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
12.09M
Enterprise Value 3
32.77M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
3.45
Price/Book (mrq)
2.19
Enterprise Value/Revenue 3
9.35
Enterprise Value/EBITDA 6
-2.59

Trading Information

Stock Price History

Beta (3Y Monthly) 0.06
52-Week Change 3-70.00%
S&P500 52-Week Change 318.29%
52 Week High 30.2800
52 Week Low 30.0400
50-Day Moving Average 30.0649
200-Day Moving Average 30.1023

Share Statistics

Avg Vol (3 month) 3563.31k
Avg Vol (10 day) 3917.5k
Shares Outstanding 5262.8M
Float 237.54M
% Held by Insiders 110.40%
% Held by Institutions 10.01%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Oct 31, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2019
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-370.62%

Management Effectiveness

Return on Assets (ttm)-26.95%
Return on Equity (ttm)-85.60%

Income Statement

Revenue (ttm)3.5M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)63.40%
Gross Profit (ttm)208.46k
EBITDA -12.64M
Net Income Avi to Common (ttm)-17.48M
Diluted EPS (ttm)-0.0700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)84.8k
Total Cash Per Share (mrq)0
Total Debt (mrq)8.85M
Total Debt/Equity (mrq)61.79
Current Ratio (mrq)0.35
Book Value Per Share (mrq)0.02

Cash Flow Statement

Operating Cash Flow (ttm)-6.4M
Levered Free Cash Flow (ttm)-12.88M